Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Prevalence of precancerous cervical lesions in women attending Mezam Polyclinic Bamenda, Cameroon.

Nkfusai NC, Mubah TM, Yankam BM, Tambe TA, Cumber SN.

Pan Afr Med J. 2019 Apr 10;32:174. doi: 10.11604/pamj.2019.32.174.16895. eCollection 2019.

2.

Evaluation of interleukin 8 and interleukin 10 cytokines in liquid based cervical cytology samples.

Osiagwu DD, Azenabor AE, Osijirin AA, Awopetu PI, Oyegbami FR.

Pan Afr Med J. 2019 Mar 26;32:148. doi: 10.11604/pamj.2019.32.148.16314. eCollection 2019.

3.

FOXP3 immunoregulatory gene variants are independent predictors of human papillomavirus infection and cervical cancer precursor lesions.

Cezar-Dos-Santos F, Ferreira RS, Okuyama NCM, Trugilo KP, Sena MM, Pereira ÉR, Pereira APL, Watanabe MAE, de Oliveira KB.

J Cancer Res Clin Oncol. 2019 Aug;145(8):2013-2025. doi: 10.1007/s00432-019-02951-x. Epub 2019 Jun 8.

PMID:
31177386
4.

Knowledge of human papillomavirus and Pap test among Brazilian university students.

Baptista AD, Simão CX, Santos VCGD, Melgaço JG, Cavalcanti SMB, Fonseca SC, Vitral CL.

Rev Assoc Med Bras (1992). 2019 Jun 3;65(5):625-632. doi: 10.1590/1806-9282.65.5.625.

5.

Sex education in Poland - a cross-sectional study evaluating over twenty thousand polish women's knowledge of reproductive health issues and contraceptive methods.

Warzecha D, Szymusik I, Pietrzak B, Kosinska-Kaczynska K, Sierdzinski J, Sochacki-Wojcicka N, Wielgos M.

BMC Public Health. 2019 Jun 3;19(1):689. doi: 10.1186/s12889-019-7046-0.

6.

Distribution of human papillomavirus infection: a population-based study of cervical samples from Jiangsu Province.

Zhang C, Cheng W, Liu Q, Guan Q, Zhang Q.

Virol J. 2019 May 20;16(1):67. doi: 10.1186/s12985-019-1175-z.

7.

The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5 years of follow-up.

Harper DM, Nieminen P, Donders G, Einstein MH, Garcia F, Huh WK, Stoler MH, Glavini K, Attley G, Limacher JM, Bastien B, Calleja E.

Gynecol Oncol. 2019 Jun;153(3):521-529. doi: 10.1016/j.ygyno.2019.03.250. Epub 2019 Apr 4.

8.

Sodium-coupled monocarboxylate transporter is a target of epigenetic repression in cervical cancer.

Hernández-Juárez J, Vargas-Sierra O, Herrera LA, Cantú De León D, Fernández-Retana J, Pérez-Plasencia C, López-Camarillo C, Gariglio P, Díaz-Chávez J.

Int J Oncol. 2019 May;54(5):1613-1624. doi: 10.3892/ijo.2019.4749. Epub 2019 Mar 14.

9.

Human papillomavirus prevalence and genotype distribution among Turkish women with or without cervical lesion.

Demirci M, Guzel AD, Ersahin AA, Yorulmaz E, Ersahin SS, Borsa BA.

Indian J Med Microbiol. 2018 Oct-Dec;36(4):517-521. doi: 10.4103/ijmm.IJMM_18_232.

PMID:
30880699
10.

Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.

Cassani B, Soldano G, Finocchiaro D, Conti S, Bulfamante A, Lemorini G, Bulfamante G.

Pathologica. 2018 Dec;110(4):294-301.

PMID:
30799441
11.

Demographics, self-efficacy, benefits/barriers, stages of adopting pap testing among Korean American women.

Tung WC, Granner M, Lu M, Sohn J.

J Obstet Gynaecol. 2019 May;39(4):510-515. doi: 10.1080/01443615.2018.1525693. Epub 2019 Feb 16.

PMID:
30773963
12.

Risk factors for pelvic and distant recurrence in locally advanced cervical cancer.

Queiroz ACM, Fabri V, Mantoan H, Sanches SM, Guimarães APG, Ribeiro ARG, da Nogueira Silveira Lima JP, Chen MJ, Baiocchi G, da Costa AABA.

Eur J Obstet Gynecol Reprod Biol. 2019 Apr;235:6-12. doi: 10.1016/j.ejogrb.2019.01.028. Epub 2019 Feb 6.

PMID:
30771718
13.

Molecular Diagnosis of Human Papilloma Virus by PCR.

Nahar F, Hossain MA, Paul SK, Ahmed MU, Khatun S, Bhuiyan GR, Nasreen SA, Haque N, Ahmed S, Kobayashi N, Akter SN, Begum H.

Mymensingh Med J. 2019 Jan;28(1):175-181.

PMID:
30755567
14.

HPV-FASTER: Combined strategies of HPV vaccination and HPV screening towards a one visit for cervical cancer preventive campaigns.

Bosch FX, Robles C.

Salud Publica Mex. 2018 Nov-Dic;60(6):612-616. doi: 10.21149/10171. No abstract available.

PMID:
30699264
15.

Oncological results and recurrent risk factors following abdominal radical trachelectomy: an updated series of 333 patients.

Li X, Li J, Jiang Z, Xia L, Ju X, Chen X, Wu X.

BJOG. 2019 Aug;126(9):1169-1174. doi: 10.1111/1471-0528.15621. Epub 2019 Feb 28.

PMID:
30663205
16.

Increasing risk of uterine cervical cancer among young Japanese women: Comparison of incidence trends in Japan, South Korea and Japanese-Americans between 1985 and 2012.

Utada M, Chernyavskiy P, Lee WJ, Franceschi S, Sauvaget C, de Gonzalez AB, Withrow DR.

Int J Cancer. 2019 May 1;144(9):2144-2152. doi: 10.1002/ijc.32014. Epub 2018 Dec 18.

PMID:
30474210
17.

[Use of human papilloma virus testing in primary cervical cancer screening in rural Madagascar].

Dumont A, Bessières N, Razafindrafara G, Ravit M, Benbassa A.

Rev Epidemiol Sante Publique. 2019 Apr;67(2):120-125. doi: 10.1016/j.respe.2018.10.003. Epub 2018 Nov 14. French.

PMID:
30448093
18.

Correlations of MicroRNA-21 Gene Polymorphisms With Chemosensitivity and Prognosis of Cervical Cancer.

Zhang J, Li YH, Liu HL, Zhang Y, Zhang QS, Li SZ.

Am J Med Sci. 2018 Dec;356(6):544-551. doi: 10.1016/j.amjms.2018.08.014. Epub 2018 Aug 29.

PMID:
30447706
19.

Factors associated with a cervical high-grade lesion on cytology or a positive visual inspection with acetic acid among more than 3300 Tanzanian women.

Baldur-Felskov B, Mwaiselage J, Faber MT, Kjaerem M, de la Cour CD, Munk C, Kahesa C, Iftner T, Rasch V, Kjaer SK.

Trop Med Int Health. 2019 Feb;24(2):229-237. doi: 10.1111/tmi.13184. Epub 2018 Dec 2.

PMID:
30444556
20.

[Cervical cancer screening in Germany].

Bujan Rivera J, Klug SJ.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Dec;61(12):1528-1535. doi: 10.1007/s00103-018-2835-7. Review. German.

PMID:
30397722

Supplemental Content

Loading ...
Support Center